Report Detail
Global (United States, European Union and China) Opioids Agonist Drugs Market Research Report 2019-2025
- RnM3681938 |
- 19 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
In 2019, the market size of Opioids Agonist Drugs is 18600 million US$ and it will reach 25900 million US$ in 2025, growing at a CAGR of 4.2% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Opioids Agonist Drugs.
This report studies the global market size of Opioids Agonist Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Opioids Agonist Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Market Segment by Product Type
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Market Segment by Application
Pain Management
Cough Treatment
Diarrhea Treatment
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Opioids Agonist Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Opioids Agonist Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Opioids Agonist Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Opioids Agonist Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Codeine
- 1.3.3 Fentanyl
- 1.3.4 Meperidine
- 1.3.5 Methadone
- 1.3.6 Morphine
- 1.3.7 Hydrocodone
- 1.4 Market Segment by Application
- 1.4.1 Global Opioids Agonist Drugs Market Share by Application (2019-2025)
- 1.4.2 Pain Management
- 1.4.3 Cough Treatment
- 1.4.4 Diarrhea Treatment
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Opioids Agonist Drugs Market Size
- 2.1.1 Global Opioids Agonist Drugs Revenue 2014-2025
- 2.1.2 Global Opioids Agonist Drugs Sales 2014-2025
- 2.2 Opioids Agonist Drugs Growth Rate by Regions
- 2.2.1 Global Opioids Agonist Drugs Sales by Regions 2014-2019
- 2.2.2 Global Opioids Agonist Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Opioids Agonist Drugs Sales by Manufacturers
- 3.1.1 Opioids Agonist Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Opioids Agonist Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Opioids Agonist Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Opioids Agonist Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Opioids Agonist Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Opioids Agonist Drugs Price by Manufacturers
- 3.4 Key Manufacturers Opioids Agonist Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Opioids Agonist Drugs Market
- 3.6 Key Manufacturers Opioids Agonist Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Codeine Sales and Revenue (2014-2019)
- 4.1.2 Fentanyl Sales and Revenue (2014-2019)
- 4.1.3 Meperidine Sales and Revenue (2014-2019)
- 4.1.4 Methadone Sales and Revenue (2014-2019)
- 4.1.5 Morphine Sales and Revenue (2014-2019)
- 4.1.6 Hydrocodone Sales and Revenue (2014-2019)
- 4.2 Global Opioids Agonist Drugs Sales Market Share by Type
- 4.3 Global Opioids Agonist Drugs Revenue Market Share by Type
- 4.4 Opioids Agonist Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Opioids Agonist Drugs Sales by Application
6 United States
- 6.1 United States Opioids Agonist Drugs Breakdown Data by Company
- 6.2 United States Opioids Agonist Drugs Breakdown Data by Type
- 6.3 United States Opioids Agonist Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Opioids Agonist Drugs Breakdown Data by Company
- 7.2 European Union Opioids Agonist Drugs Breakdown Data by Type
- 7.3 European Union Opioids Agonist Drugs Breakdown Data by Application
8 China
- 8.1 China Opioids Agonist Drugs Breakdown Data by Company
- 8.2 China Opioids Agonist Drugs Breakdown Data by Type
- 8.3 China Opioids Agonist Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Opioids Agonist Drugs Breakdown Data by Company
- 9.2 Rest of World Opioids Agonist Drugs Breakdown Data by Type
- 9.3 Rest of World Opioids Agonist Drugs Breakdown Data by Application
- 9.4 Rest of World Opioids Agonist Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Opioids Agonist Drugs Sales by Countries
- 9.4.2 Rest of World Opioids Agonist Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Purdue Pharma
- 10.1.1 Purdue Pharma Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
- 10.1.4 Opioids Agonist Drugs Product Introduction
- 10.1.5 Purdue Pharma Recent Development
- 10.2 Titan pharmaceuticals
- 10.2.1 Titan pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
- 10.2.4 Opioids Agonist Drugs Product Introduction
- 10.2.5 Titan pharmaceuticals Recent Development
- 10.3 Boehringer Ingelheim
- 10.3.1 Boehringer Ingelheim Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
- 10.3.4 Opioids Agonist Drugs Product Introduction
- 10.3.5 Boehringer Ingelheim Recent Development
- 10.4 Janssen Pharmaceuticals, Inc
- 10.4.1 Janssen Pharmaceuticals, Inc Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
- 10.4.4 Opioids Agonist Drugs Product Introduction
- 10.4.5 Janssen Pharmaceuticals, Inc Recent Development
- 10.5 Sanofi
- 10.5.1 Sanofi Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
- 10.5.4 Opioids Agonist Drugs Product Introduction
- 10.5.5 Sanofi Recent Development
- 10.6 Sun Pharmaceuticals
- 10.6.1 Sun Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
- 10.6.4 Opioids Agonist Drugs Product Introduction
- 10.6.5 Sun Pharmaceuticals Recent Development
- 10.7 Mallinckrodt Pharmaceuticals
- 10.7.1 Mallinckrodt Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
- 10.7.4 Opioids Agonist Drugs Product Introduction
- 10.7.5 Mallinckrodt Pharmaceuticals Recent Development
- 10.8 Egalet Corporation
- 10.8.1 Egalet Corporation Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
- 10.8.4 Opioids Agonist Drugs Product Introduction
- 10.8.5 Egalet Corporation Recent Development
- 10.9 Endo Pharmaceuticals Inc.
- 10.9.1 Endo Pharmaceuticals Inc. Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
- 10.9.4 Opioids Agonist Drugs Product Introduction
- 10.9.5 Endo Pharmaceuticals Inc. Recent Development
- 10.10 Allergan, Plc
- 10.10.1 Allergan, Plc Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Opioids Agonist Drugs
- 10.10.4 Opioids Agonist Drugs Product Introduction
- 10.10.5 Allergan, Plc Recent Development
- 10.11 Pfizer Inc
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Opioids Agonist Drugs Sales Channels
- 11.2.2 Opioids Agonist Drugs Distributors
- 11.3 Opioids Agonist Drugs Customers
12 Market Forecast
- 12.1 Global Opioids Agonist Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Opioids Agonist Drugs Sales Forecast by Type
- 12.3 Global Opioids Agonist Drugs Sales Forecast by Application
- 12.4 Opioids Agonist Drugs Forecast by Regions
- 12.4.1 Global Opioids Agonist Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Opioids Agonist Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Opioids Agonist Drugs. Industry analysis & Market Report on Opioids Agonist Drugs is a syndicated market report, published as Global (United States, European Union and China) Opioids Agonist Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Opioids Agonist Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
